Comprehensive disclaimer language for SirenMold.com

Below is ready-to-publish disclaimer content written in plain English and organized into clearly-headed sections you can drop into a webpage (or split across linked pages such as /disclaimer, /terms, /privacy, /community-guidelines, and /dmca). Each section is self-contained so you can move sections around without breaking internal logic.

A note before the text: this is a carefully compiled, protective template that draws on language patterns from Mayo Clinic, Cleveland Clinic, Peter Attia/Early Medical, Examine.com, SelfDecode, Chris Kresser, Surviving Mold, ISEAI, Inspire.com, Phoenix Rising, and standard FTC/FDA/CCPA/DMCA/ADA frameworks. It is not a substitute for review by a California-licensed attorney, which is strongly recommended before publication given that the site discusses prescription medications, peptides in regulatory gray areas, and one patient’s active treatment protocol.

---

Important notices — please read before using this site

Last updated: [DATE]. Version [X.X]. A full changelog of material changes is maintained at [/changelog].

SirenMold.com (“SirenMold,” “we,” “us,” or “our”) is a free, non-profit, patient-built educational project based in California. We do not sell products, supplements, services, memberships, tests, or consultations. We have no affiliate links, sponsorships, or commercial partnerships. The site exists to share research, one patient’s lived experience with invasive aspergillosis and mold-related illness, and a moderated community space for patients, clinicians, and researchers.

By using this site you confirm that you are at least 18 years old, that you have read the notices below, and that you accept them. If you do not agree with any part, please stop using the site.

---

1. Medical disclaimer — this is not medical advice

Everything on SirenMold.com is for general educational and informational purposes only. It is not medical advice, diagnosis, or treatment, and it is not a substitute for the professional judgment of a licensed clinician who knows you and your history.

Using this site — reading articles, browsing the case study, posting in the forum, messaging an author, subscribing to the newsletter, or interacting with any practitioner who participates here — does not create a doctor-patient, therapist-client, pharmacist-patient, or any other professional relationship between you and SirenMold, its authors, moderators, or contributors. No contributor, whether or not they hold a professional license, is acting as your clinician when they post here.

A large portion of this site describes one individual’s ongoing treatment for active invasive aspergillosis, including a protocol of more than seventy compounds. That is what researchers call an “n-of-1” case study. One person’s experience — even when it is thoroughly documented and cross-referenced to the literature — does not predict what will happen in anyone else. Your genetics, other diagnoses, drug metabolism (including CYP450 variants), microbiome, environmental exposures, age, sex, pregnancy status, organ function, and concurrent medications can change outcomes dramatically, including turning a compound that helped one person into one that harms another.

Many of the compounds discussed on this site require medical supervision. Prescription antifungals such as itraconazole and voriconazole have narrow therapeutic windows, serious drug–drug interactions through CYP3A4 and other cytochrome P450 enzymes, risks including hepatotoxicity, QT prolongation, neurotoxicity, and adrenal suppression, and require therapeutic drug monitoring. Peptides such as thymosin alpha-1, BPC-157, and selank are discussed for their mechanisms and reported effects; several of these peptides are not approved by the U.S. Food and Drug Administration for any human indication, some appear on the FDA’s 503A “Category 2” bulks list (meaning compounding pharmacies generally cannot prepare them for human use), and products sold with “research use only” or “not for human consumption” labels are not safety-tested for people. Supplements and botanicals discussed here — including d-ribose, CoQ10, NAD+ precursors, PQQ, allicin, and lactoferrin — can interact with prescription drugs, affect coagulation, liver enzymes, and blood pressure, and are not risk-free because they are sold over the counter.

Do not start, stop, change the dose of, or combine any medication, peptide, supplement, or botanical based on anything you read here. Bring what you learn to a qualified clinician who can evaluate it against your personal health picture, order appropriate monitoring, and take responsibility for your care.

If you are having a medical emergency, stop reading and call 911 or go to your nearest emergency department now. This includes signs of severe infection, breathing difficulty, chest pain, suicidal thoughts, severe allergic reaction, or any rapidly worsening symptom. Do not use the forum, the newsletter, email, or any other feature of this site to communicate an emergency. We do not monitor communications in real time and we cannot respond to urgent medical needs.

We make reasonable efforts to keep information accurate and current, but we make no guarantee of accuracy, completeness, timeliness, or clinical applicability. Medicine changes quickly. Drug labels, dosing, and safety data are updated by regulators and manufacturers. Always verify any fact that matters to your care against a primary source such as the current FDA label, your pharmacist, or your physician.

---

2. About the case study and self-reported outcomes

The case study on this site is written by the patient it describes. Outcomes, symptoms, labs, and subjective reports are self-reported and have not been independently verified, peer-reviewed, or replicated. Benefits attributed to a given compound may reflect placebo response, regression to the mean, concurrent treatment, spontaneous improvement, measurement error, or factors unknown to the author. Harms not mentioned in the case study may still occur in other people. Nothing about the case study should be read as a recommendation, a protocol, or a template for your own treatment. It is a narrative record maintained in the spirit of open scientific sharing, and it carries all the limitations of any single anecdote.

---

3. Health information disclaimer — individual results vary

Human biology is variable. Information that is true in aggregate is not necessarily true for you, and information that helped one patient may not help — or may harm — another. Individual response to any intervention depends on factors including genetic polymorphisms (for example, CYP2C19, CYP3A4/5, MTHFR, HLA type, and detoxification genes), gut and airway microbiome, exposure history, comorbidities, pregnancy or breastfeeding status, hormonal status, kidney and liver function, concurrent prescription and over-the-counter medications, supplements, and diet.

Prescription medications discussed on this site require a prescription from a licensed clinician and ongoing medical oversight. It is illegal in the United States to obtain prescription-only drugs without a valid prescription, and doing so bypasses the safety monitoring that makes these drugs usable in the first place.

Compound interactions and contraindications are real and sometimes life-threatening. Azole antifungals interact with dozens of commonly prescribed drugs through CYP450 enzymes and P-glycoprotein, including statins, benzodiazepines, anticoagulants, immunosuppressants, some antidepressants, and many others. Peptides, botanicals, and supplements can interact with prescription drugs as well — for example, allicin and high-dose fish oil affect platelet function; lactoferrin can affect iron status; NAD+ precursors can alter methylation; and many botanicals induce or inhibit liver enzymes.

Not all compounds discussed on this site have been evaluated by the FDA for the uses described. Dietary supplements are not reviewed by FDA for safety or efficacy before they reach the market. In the statutory language required of supplement labeling: “These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.” That statutory framing applies, in spirit, to every supplement and botanical discussed here.

---

4. Research, citations, and evolving science

SirenMold cites peer-reviewed research with PubMed IDs and DOIs so that readers can verify claims at the source. Citation of a study does not imply that the study’s findings apply to any specific patient, that the intervention studied is safe or effective outside the study’s context, or that regulators have approved the use being discussed.

We take care to distinguish among different tiers of evidence, but readers should do the same:

• In vitro evidence (cells or molecules in a dish) describes what a compound can do under artificial conditions. It does not prove that the compound does the same thing inside a human body at tolerable doses.
• Animal evidence is suggestive and mechanistically useful, but many effects that appear in mice do not translate to humans, and dosing does not scale directly.
• Human clinical evidence ranges from case reports and small open-label series (low certainty) to randomized controlled trials and meta-analyses (higher certainty). Even high-quality trials can be overturned by later work.

Some applications discussed on this site are off-label, investigational, or based on mechanistic extrapolation from preclinical data. Off-label use of an FDA-approved drug is legal when prescribed by a clinician who judges it appropriate, but it shifts more of the responsibility for safety onto that clinician and the patient. Mechanistic reasoning — “this compound should work because it hits this pathway” — is a hypothesis, not a conclusion. We try to flag the evidence tier in each article, but readers should assume that any novel application is unproven until a qualified clinician confirms otherwise.

Science evolves. Information on this site may become outdated, contradicted, or corrected without notice. When we learn that a page contains an error or a now-superseded claim, we update the page and log the change at [/changelog]. If you believe something on the site is wrong, please email [corrections@sirenmold.com] with the URL and the specific issue; we will review and, where appropriate, correct and annotate the page.

---

5. Community forum — user-generated content

The SirenMold community forum is a space for patients, caregivers, clinicians, and researchers to share experiences and discuss the literature. Posts, comments, replies, and private messages in the forum are the sole responsibility of the person who wrote them. They are not written, reviewed, endorsed, verified, or adopted by SirenMold, and they do not represent SirenMold’s views.

Forum content — public or within private practitioner areas — is not medical advice and does not create a doctor-patient relationship, even if the person posting is a licensed clinician and even within areas reserved for verified practitioners. Clinicians who participate in the forum do so as individuals sharing perspective and literature, not as your treating provider. Share information about your own experience if you wish, but do not ask other forum members to diagnose you, prescribe for you, or direct your care. If you are a clinician posting here, do not provide individualized clinical advice through the forum.

SirenMold operates a practitioner verification program that confirms a basic credential (for example, a current state license) at the time of verification. Verification is a light-touch check, not a vouch for competence, scope of practice, current licensure status, disciplinary history, malpractice history, or the accuracy of any specific claim the practitioner makes. We do not independently audit practitioner posts. A practitioner’s verified status can be revoked at our discretion and does not create any relationship between SirenMold and that person’s patients.

We moderate the forum in good faith — removing spam, harassment, doxxing, illegal content, content that poses an imminent safety risk, and content that plainly violates the community guidelines — but we cannot read or verify every post, cannot confirm the truth of anyone’s claims about their own credentials, diagnoses, labs, or outcomes, and make no promise that any particular post will be reviewed, retained, or removed. We reserve the right, but not the obligation, to moderate at our sole discretion. Consistent with Section 230 of the Communications Decency Act (47 U.S.C. § 230), SirenMold is not the publisher or speaker of content posted by users, and the fact that we moderate some content does not make us responsible for content we do not remove.

Do not post anything in the forum that you would not want to be public or that identifies another person without their consent. SirenMold is not a HIPAA-covered entity, and information you voluntarily share in forum posts is not protected health information under HIPAA. Once you post, other members and the broader internet may see, copy, or share that content. Use the forum with that in mind.

---

6. General website disclaimer — accuracy, warranties, and your own risk

SirenMold.com is provided on an “as is” and “as available” basis. We make no representation or warranty — express, implied, or statutory — about the site, including about accuracy, completeness, reliability, currency, availability, non-infringement, fitness for a particular purpose, or merchantability. Content may be added, revised, moved, or removed without notice.

Your use of the site, and any reliance you place on any information here, is entirely at your own risk. To the fullest extent permitted by California and federal law, SirenMold and its authors, moderators, volunteers, and contributors are not liable for any direct, indirect, incidental, consequential, special, exemplary, or punitive damages — including personal injury, medical harm, lost data, lost profits, or lost opportunity — arising from your use of, or inability to use, the site, even if we have been advised that such damages are possible. Some jurisdictions do not allow certain limitations, so parts of this limitation may not apply to you; in that case, our liability is limited to the minimum permitted by law.

If any part of these notices is found unenforceable, the remaining parts continue in full effect. These notices are governed by the laws of the State of California, without regard to conflict-of-law principles, and disputes will be heard in the state or federal courts located in [County], California.

---

7. External links

This site links to outside resources, including PubMed, journal publishers, government agencies, other research databases, community forum posts, and occasional blogs, podcasts, or videos. We link to these sources because they are informative, not because we endorse everything on them. We do not control third-party sites, do not monitor their content, and are not responsible for their accuracy, privacy practices, availability, or any harm that may come from using them. When you follow an external link you are subject to that site’s own terms and privacy policy; please read them.

---

8. Email, newsletter, and privacy

If you subscribe to the newsletter, we collect the email address you give us and, where you choose to provide it, a first name. We use your email only to send the newsletter and occasional updates about SirenMold. We do not sell, rent, trade, or share your email address with advertisers or data brokers, ever.

We use Mailchimp (Intuit Mailchimp) as our third-party email service provider. When you subscribe, your email address and related subscription data are transmitted to and stored by Mailchimp on our behalf, subject to Mailchimp’s own terms and privacy policy at mailchimp.com/legal. By subscribing, you consent to that processing.

Every newsletter email contains a one-click unsubscribe link. We honor unsubscribe requests within ten business days, as required by the CAN-SPAM Act, and each email includes a valid physical mailing address as the law requires.

California residents: SirenMold is a non-profit educational project that does not sell personal information and does not meet the for-profit revenue or volume thresholds that trigger most obligations of the California Consumer Privacy Act and California Privacy Rights Act. We nonetheless aim to honor the core rights those laws protect. You may request that we tell you what information we have about you, correct it, or delete it, by emailing

[privacy@sirenmold.com]. We will respond within 45 days or explain why we need more time. We will never discriminate against you for exercising these rights.

We do not knowingly serve users under 18 and do not knowingly collect information from anyone under 13. If you believe a child under 13 has submitted information to us, please email [privacy@sirenmold.com] and we will delete it promptly.

Our full privacy policy at [/privacy]

describes cookies, analytics, server logs, and retention periods in more detail.

---

9. Copyright, fair use, and corrections

Original text, figures, the case study narrative, site design, and compilations on SirenMold.com are © [YEAR] SirenMold and its authors, all rights reserved. Unless stated otherwise on a specific page, you may quote short passages for non-commercial educational purposes with attribution and a link back to the source page. Redistribution of full articles, the case study, or the protocol in any form requires written permission.

SirenMold cites peer-reviewed research, FDA labeling, and other published sources for educational commentary, criticism, and scholarship. Our use of copyrighted third-party material — such as brief quotations, figures reproduced with attribution, or summaries of study findings — is intended to qualify as fair use under 17 U.S.C. § 107, based on the non-commercial educational purpose, the limited amount used, and the transformative nature of our analysis. Fair use is a legal defense, not a license; copyright in cited works remains with the original authors and publishers.

If you own a copyright and believe material on this site infringes your rights, please send a DMCA notice to our designated agent at [dmca@sirenmold.com]. Your notice should include (1) a physical or electronic signature, (2) identification of the work claimed to be infringed, (3) the URL of the allegedly infringing material, (4) your contact information, (5) a good-faith statement that the use is not authorized, and (6) a statement under penalty of perjury that your information is accurate and you are authorized to act for the copyright owner. We will respond promptly and will terminate accounts of repeat infringers.

Non-DMCA correction requests — for example, a researcher who feels their work was characterized incorrectly, or anyone who spots a factual error — should go to [corrections@sirenmold.com]. We take these seriously, respond in writing, and log material corrections on the public changelog.

---

10. Accessibility

SirenMold aims to be usable by everyone, including people who rely on assistive technology. We work toward conformance with the Web Content Accessibility Guidelines (WCAG) 2.2 Level AA. If you encounter a barrier — a screen-reader problem, low contrast, a missing caption, a keyboard-navigation issue — please email [accessibility@sirenmold.com] and we will fix it as quickly as we can and offer the information in an alternative format in the meantime.

---

11. Changes to these notices

We will update these notices from time to time. The date at the top of this page is the effective date of the current version. Material changes are announced at the top of the site for at least 30 days and recorded in the [/changelog]. Continued use of the site after the effective date of a change means you accept the updated notices. If you disagree, please stop using the site.

---

12. Contact

• General and corrections: [hello@sirenmold.com] / [corrections@sirenmold.com]
• Privacy and data requests: [privacy@sirenmold.com]
• DMCA notices: [dmca@sirenmold.com]
• Accessibility: [accessibility@sirenmold.com]
• Mailing address (required for CAN-SPAM): [P.O. Box or street address, City, CA, ZIP]

---

Implementation checklist

A few practical notes on how to deploy the language above:

1. Place a persistent footer link labeled “Disclaimer & Legal” that opens this page, and repeat a short “Not medical advice — read full disclaimer” banner at the top of the case study and any page that names prescription drugs, peptides, or specific doses.
2. On the newsletter signup form, include a short notice-at-collection sentence (“We use Mailchimp to send the newsletter, we never sell your email, unsubscribe anytime — full privacy policy here”) linked to section 8.
3. On the forum, require new accounts to tick a box confirming they have read sections 1, 2, 3, and 5, and display a condensed reminder above the reply box.
4. Keep the public changelog granular — each material content change should have a dated entry with the page affected and a one-line description.
5. Before launch, have a California-licensed attorney familiar with health-information liability, Section 230, and FDA issues review the full set — peptide coverage and the documented active-treatment protocol are the two areas most likely to draw regulatory or tort attention, and counsel may want to tighten language specific to those.